Every revenue stream emerges from the same intelligence core. Nothing is bolted on. Everything compounds.
Seven revenue streams distributed across three concentric rings
The foundation. Recurring SaaS revenue from tiered intelligence delivery.
Direct sales from walkthrough → dossier → deployment call pipeline. Upsell from Signal to higher tiers as organizations see compounding value.
Unlike consulting (project-based), intelligence compounds. Cancellation means losing institutional memory.
When the intelligence engine detects a client need that matches a partner specialty, it routes a warm, context-rich introduction.
Insurance specialists, regulatory consultants, BD/licensing advisors, IP attorneys, clinical trial consultants, market access strategists.
Build opt-in partner directory. Engine detects need from client signals. Referral fee on successful engagement (15-25% of first engagement or ongoing rev-share).
Zero incremental CAC. Partners get pre-qualified leads they can't access elsewhere. Clients get vetted experts at the exact moment of need.
Single-seat clients expand to multi-seat, multi-department, and eventually white-label deployments.
Land with one champion (usually BD or strategy lead), expand to executive team, then research, then regulatory. Each department gets role-specific views. Enterprise contracts replace individual subscriptions.
Once institutional memory accumulates, switching costs become enormous. The system knows their competitors, their pipeline, their regulatory timeline.
Anonymized, aggregated intelligence reports sold to the broader industry. Sector-level insights derived from the collective intelligence of all client deployments.
Once sufficient client base exists (50+ organizations), aggregate anonymized signals into quarterly sector reports. Sell to investment banks, consulting firms, government agencies.
Data is already being processed. Aggregation and anonymization create a new product at near-zero marginal cost.
AI literacy and intelligence operations courses for biopharma professionals.
Intelligence-driven decision-making, AI literacy for regulated environments, and AimwellBio platform mastery. Certification becomes industry-recognized.
Positions AimwellBio as the authority on biopharma intelligence. Trained users become advocates and buyers.
National health agencies, government pharmaceutical organizations, and sovereign wealth-backed health initiatives.
Purpose-built deployments with data sovereignty (in-country hosting), custom compliance frameworks, and dedicated support. Entry through existing enterprise relationships or direct government procurement.
Governments spend billions on health intelligence with fragmented, outdated tools. A verified, sovereign-deployable intelligence system fills an enormous gap.
Expert network directory where partners are surfaced contextually to clients who need them.
Partners opt in and set availability. Engine matches client needs to partner expertise. Platform facilitates introduction. Revenue share on successful engagements.
Marketplace effect — more partners attract more clients, more clients attract more partners. AimwellBio captures margin on every transaction.
Conservative scaling model with early focus on subscription foundation
Every client deployment makes the engine smarter. Every partner integration creates a new revenue surface. Every data point processed increases the switching cost for every organization that depends on it. This is not a product roadmap. This is a compounding machine.